We note the admission of Umuthi Healthcare Solutions plc on Wednesday 3 March 2021 to the Standard Segment of the LSE.
Our name is listed on two Accountant’s Reports for Umuthi Healthcare Solutions plc and Lems Pharmaceutical Limited included in a supplemental prospectus dated 26 February 2021.
We have not approved these Accountant’s Reports and have not given our consent to their issue or the use of our name within the prospectus.